Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mie Mie Thinn"'
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Squamous cell carcinoma of head and neck (SCCHN) is the fifth most common cancer worldwide. Inhibition of epidermal growth factor receptor signaling has been shown to be a critical component of therapeutic option. Herein, we report a case
Publikováno v:
Journal of Oncology Practice. 14:52-54
Publikováno v:
The American Journal of Case Reports
Patient: Male, 68-year-old Final Diagnosis: Salivary duct carcinoma Symptoms: Bone pain • dyspnea Medication:— Clinical Procedure: Chemotherapy Specialty: Oncology Objective: Rare disease Background: Salivary duct carcinoma (SDC) is a rare, aggre
Publikováno v:
Hepatic Medicine : Evidence and Research
Sorafenib is an oral multiple kinase inhibitor that blocks Raf, vascular endothelial growth factor receptor, and platelet-derived growth factor receptor. It has been approved in the US and Europe for the treatment of advanced hepatocellular carcinoma
Publikováno v:
Blood. 120:757-757
Abstract 757 Background: Chronic lymphocytic leukemia (CLL) is the most common leukemia seen in adults. Previous population-based research in CLL has not represented the current ethnic makeup and diversity within the US population. We undertook a lar
Publikováno v:
Hepatic Medicine: Evidence & Research; 2010, Vol. 2, p147-155, 9p
Publikováno v:
Journal of Oncology Practice. Jan2018, Vol. 14 Issue 1, p52-54. 4p.